Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1980 1
1981 1
1983 1
1984 1
1985 2
1986 1
1988 1
1991 1
1995 3
1996 4
1997 3
1998 5
2000 11
2001 16
2002 10
2003 7
2004 12
2005 22
2006 35
2007 24
2008 41
2009 36
2010 53
2011 57
2012 53
2013 63
2014 60
2015 63
2016 63
2017 68
2018 41
2019 27
2020 25
2021 42
2022 43
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

819 results

Results by year

Filters applied: . Clear all
Page 1
Exercise and Type 2 Diabetes.
Amanat S, Ghahri S, Dianatinasab A, Fararouei M, Dianatinasab M. Amanat S, et al. Adv Exp Med Biol. 2020;1228:91-105. doi: 10.1007/978-981-15-1792-1_6. Adv Exp Med Biol. 2020. PMID: 32342452 Review.
Exercise improves blood glucose control in type 2 diabetes, reduces cardiovascular risk factors, and regulates body weight by reducing body fat percentage and enhancing lean mass. ...
Exercise improves blood glucose control in type 2 diabetes, reduces cardiovascular risk factors, and regulates body weight by redu
Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring.
Jackson MA, Ahmann A, Shah VN. Jackson MA, et al. Diabetes Technol Ther. 2021 Mar;23(S1):S27-S34. doi: 10.1089/dia.2021.0007. Diabetes Technol Ther. 2021. PMID: 33534631 Free PMC article. Review.
The role of continuous glucose monitoring (CGM) in type 1 diabetes (T1D) is well established in improving glycemic control and reducing hypoglycemia. Type 2 diabetes (T2D) is more prevalent than T1D and management of T2D is more heterogeneous, requiring treatment ranging f …
The role of continuous glucose monitoring (CGM) in type 1 diabetes (T1D) is well established in improving glycemic control and reducing
Finerenone in diabetic kidney disease: A systematic review and critical appraisal.
Singh AK, Singh A, Singh R, Misra A. Singh AK, et al. Diabetes Metab Syndr. 2022 Oct;16(10):102638. doi: 10.1016/j.dsx.2022.102638. Epub 2022 Oct 4. Diabetes Metab Syndr. 2022. PMID: 36223666 Review.
CONCLUSIONS: In short-term studies in patients with CKD and reduced ejection heart failure, with or without T2D, finerenone 20 mg appears to have a better renal outcome compared with spironolactone and a better mortality outcome compared with eplerenone, with significantly …
CONCLUSIONS: In short-term studies in patients with CKD and reduced ejection heart failure, with or without T2D, finerenone 20 mg app …
Effect of resistance training on HbA1c in adults with type 2 diabetes mellitus and the moderating effect of changes in muscular strength: a systematic review and meta-analysis.
Jansson AK, Chan LX, Lubans DR, Duncan MJ, Plotnikoff RC. Jansson AK, et al. BMJ Open Diabetes Res Care. 2022 Mar;10(2):e002595. doi: 10.1136/bmjdrc-2021-002595. BMJ Open Diabetes Res Care. 2022. PMID: 35273011 Free PMC article. Review.
Twenty studies (n=1172) were included in the meta-analysis. RT significantly reduced HbA1c compared with controls (weighted mean difference=-0.39, 95% CI -0.60 to -0.18, p<0.001, I(2)=69.20). ...Importantly, RT interventions that had a larger training effect appeared mo …
Twenty studies (n=1172) were included in the meta-analysis. RT significantly reduced HbA1c compared with controls (weighted mean diff …
User's guide to mechanism of action and clinical use of GLP-1 receptor agonists.
Shaefer CF Jr, Kushner P, Aguilar R. Shaefer CF Jr, et al. Postgrad Med. 2015;127(8):818-26. doi: 10.1080/00325481.2015.1090295. Epub 2015 Sep 15. Postgrad Med. 2015. PMID: 26371721 Review.
The GLP-1RAs have been shown to significantly improve glycemic parameters and reduce body weight. These agents work by activating GLP-1 receptors in the pancreas, which leads to enhanced insulin release and reduced glucagon release-responses that are both glucose-de …
The GLP-1RAs have been shown to significantly improve glycemic parameters and reduce body weight. These agents work by activating GLP …
Once-weekly basal insulin icodec: Looking ONWARDS from pharmacology to clinical trials.
Singh AK, Singh A, Singh R, Misra A. Singh AK, et al. Diabetes Metab Syndr. 2022 Sep;16(9):102615. doi: 10.1016/j.dsx.2022.102615. Epub 2022 Sep 7. Diabetes Metab Syndr. 2022. PMID: 36108418 Review.
CONCLUSION: A brighter prospect of once-weekly insulin icodec is on the card in particular in type 2 diabetes in terms of reducing injection pricks by >85% vs. once-daily basal insulin analogs, although few unknowns still exist....
CONCLUSION: A brighter prospect of once-weekly insulin icodec is on the card in particular in type 2 diabetes in terms of reducing in …
Management of Diabetes Mellitus in Patients With CKD: Core Curriculum 2022.
Hahr AJ, Molitch ME. Hahr AJ, et al. Am J Kidney Dis. 2022 May;79(5):728-736. doi: 10.1053/j.ajkd.2021.05.023. Epub 2021 Sep 30. Am J Kidney Dis. 2022. PMID: 34600745 Review.
CKD alters the relationship of glucose levels to measures of long-term control, such as hemoglobin A(1c). Medications used to treat DM may need dose adjustments as CKD progresses. ...Insulin and sulfonylureas increase the risk of hypoglycemia, some glucagon-like pep …
CKD alters the relationship of glucose levels to measures of long-term control, such as hemoglobin A(1c). Medications used to …
Glycaemic management in diabetes: old and new approaches.
Ceriello A, Prattichizzo F, Phillip M, Hirsch IB, Mathieu C, Battelino T. Ceriello A, et al. Lancet Diabetes Endocrinol. 2022 Jan;10(1):75-84. doi: 10.1016/S2213-8587(21)00245-X. Epub 2021 Nov 15. Lancet Diabetes Endocrinol. 2022. PMID: 34793722 Review.
A modern approach to glycaemic control should focus not only on reaching and maintaining optimal HbA(1c) concentrations as early as possible, but to also do so by reducing postprandial hyperglycaemia, glycaemic variability, and to extend as much as possible the time in ran …
A modern approach to glycaemic control should focus not only on reaching and maintaining optimal HbA(1c) concentrations as early as possible …
Effectiveness of Strategies for Nutritional Therapy for Patients with Type 2 Diabetes and/or Hypertension in Primary Care: A Systematic Review and Meta-Analysis.
Simões Corrêa Galendi J, Leite RGOF, Banzato LR, Nunes-Nogueira VDS. Simões Corrêa Galendi J, et al. Int J Environ Res Public Health. 2022 Apr 2;19(7):4243. doi: 10.3390/ijerph19074243. Int J Environ Res Public Health. 2022. PMID: 35409925 Free PMC article. Review.
With a moderate quality of evidence, educational/counseling programs and food replacement programs in primary care likely reduce HbA1c on patients with T2DM (mean difference (MD): -0.37, 95% CI: -0.57 to -0.17, 7437 patients, 27 studies; MD: -0.54, 95% CI: -0.75 to -0.32, …
With a moderate quality of evidence, educational/counseling programs and food replacement programs in primary care likely reduce HbA1 …
Carbohydrate Counting in Children and Adolescents with Type 1 Diabetes.
Tascini G, Berioli MG, Cerquiglini L, Santi E, Mancini G, Rogari F, Toni G, Esposito S. Tascini G, et al. Nutrients. 2018 Jan 22;10(1):109. doi: 10.3390/nu10010109. Nutrients. 2018. PMID: 29361766 Free PMC article. Review.
Evidence suggests that CC may have positive effects on metabolic control and on reducing glycosylated haemoglobin concentration (HbA(1c)). Moreover, CC might reduce the frequency of hypoglycaemia. ...In conclusion, in children and adolescents with T1D, CC may have a …
Evidence suggests that CC may have positive effects on metabolic control and on reducing glycosylated haemoglobin concentration (HbA( …
819 results